Psychopathology Research Unit - University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT00149773
This study will assess the effectiveness of cognitive therapy in reducing the incidence of suicide ideation and behavior in older men in a primary care setting.
Looking for future studies?
Notify Me60 year and older
Male
Interventional
Phase 1
Philadelphia, Pennsylvania, 19104, United States
Older adult males have the highest suicide rate of any age group in the U.S. Over 70 percent of older suicide victims have been to their primary care physician within a month of their death, many with a depressive illness that was not detected. However, most research concerning treatments for suicide ideation and behavior has focused on adolescents and young adults. Very few treatments have been developed to reduce suicide ideation and behavior in men aged 60 and above. This study will assess the effectiveness of specialized cognitive therapy versus typical treatment in treating older men with suicide ideation.
Participants in this two-year, single-blind study will be randomly assigned to receive either cognitive therapy combined with enriched care or enriched care alone. Participants will be identified in primary care settings as having experienced suicide ideation in the past month. Cognitive therapy will be provided by Ph.D.-level therapists and will be geared specifically toward older men with suicidal tendencies. The enriched care condition will consist of the usual care that individuals receive for suicide prevention, plus assessment and referral services provided by independent evaluators and study case managers. All participants will be assessed pre-treatment to attain baseline measures of suicide ideation, hopelessness, and depression. Study visits will occur at baseline and Months 1, 3, 6, 12, 18, and 24 to assess suicide ideation. Self-report and clinician-administered measures will be used to assess participants' progress.
For information on a related study, please follow this link:
http://clinicaltrials.gov/show/NCT00218725
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1, 3, 6, 12, 18, and 24 months
Time frame: 1, 3, 6, 12, 18, and 24 months
Time frame: 1, 3, 6, 12, 18, and 24 months
Time frame: 1, 3, 6, 12, 18, and 24 months
University of Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282225
Behavior, Behavioral Symptoms
Ann Arbor, Michigan, United States
View Trial DetailsNCT06406972
Behavior, Behavioral Symptoms
Lund, Skåne County, Sweden
View Trial DetailsNCT05202756
Behavior, Behavioral Symptoms
Providence, Rhode Island, United States
View Trial DetailsNCT01123174
Behavior, Behavioral Symptoms
Angers, France
View Trial Details